EBS Pharma

Emergent BioSolutions is a global life sciences company focused on providing preparedness and response solutions for accidental, intentional, and naturally occurring public health threats. The company is best known for its portfolio of medical countermeasures, including Narcan (naloxone HCl) nasal spray for opioid overdose reversal and vaccines for anthrax and smallpox. Beyond its proprietary products, Emergent operates as a contract development and manufacturing organization (CDMO), providing services to government agencies and pharmaceutical companies. The company plays a critical role in national biodefense strategies and global health security through its specialized manufacturing capabilities and long-term government procurement contracts.